KZIA
Kazia Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 0
Consensus Rating "Strong Buy"
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About KZIA
Kazia Therapeutics Limited
An Australian developer of pharmaceuticals based on super benzopyran and anti tropomyosin technology platforms
Biological Technology
--
01/07/1999
NASDAQ Stock Exchange
6
06-30
Depository Receipts (Ordinary Shares)
Three International Towers, Level 24, 300 Barangaroo Avenue, Sydney, New South Wales 2000, Australia
--
Kazia Therapeutics Limited was established in March 1994 and is registered in New South Wales, Australia. The company is engaged in drug development, with a primary focus on oncology. Kazia is an emerging biotechnology business with a portfolio of development candidates spanning multiple technologies that aim to advance innovative therapies for a variety of cancer indications and provide new therapies that address unmet medical needs.
Company Financials
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
